Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services.
Johnson & Johnson will be a participant in the 37th Annual JP Morgan Health Care Conference. The conference will take place on Monday, January 7th, 2019 at the Westin St. Francis in San Francisco, CA. The company will be represented by three individuals during a session scheduled for 2:30 p.m. Pacific Time: Joseph J. Wolk, Executive Vice President and Chief Financial Officer; Jennifer Taubert, Executive Vice President, Pharmaceuticals; and Ashley McEvoy, Executive Vice President, Medical Devices. Alex Gorsky, the Chairman and Chief Executive Officer will join the team for a Q&A session at 3:00 p.m. Pacific Time.
Both sessions will be available to investors and those interested through the Johnson & Johnson website www.investor.jnj.com. A recording of the webcasts and podcast will be available two hours following each event.